Development of an Australia and New Zealand Lung Cancer Clinical Quality Registry: a protocol paper
Details
Publication Year 2022-08-29,Volume 12,Issue #8,Page e060907
Journal Title
BMJ Open
Publication Type
Protocol
Abstract
INTRODUCTION: Lung cancer is the leading cause of cancer mortality, comprising the largest national cancer disease burden in Australia and New Zealand. Regional reports identify substantial evidence-practice gaps, unwarranted variation from best practice, and variation in processes and outcomes of care between treating centres. The Australia and New Zealand Lung Cancer Registry (ANZLCR) will be developed as a Clinical Quality Registry to monitor the safety, quality and effectiveness of lung cancer care in Australia and New Zealand. METHODS AND ANALYSIS: Patient participants will include all adults >18 years of age with a new diagnosis of non-small-cell lung cancer (NSCLC), SCLC, thymoma or mesothelioma. The ANZLCR will register confirmed diagnoses using opt-out consent. Data will address key patient, disease, management processes and outcomes reported as clinical quality indicators. Electronic data collection facilitated by local data collectors and local, state and federal data linkage will enhance completeness and accuracy. Data will be stored and maintained in a secure web-based data platform overseen by registry management. Central governance with binational representation from consumers, patients and carers, governance, administration, health department, health policy bodies, university research and healthcare workers will provide project oversight. ETHICS AND DISSEMINATION: The ANZLCR has received national ethics approval under the National Mutual Acceptance scheme. Data will be routinely reported to participating sites describing performance against measures of agreed best practice and nationally to stakeholders including federal, state and territory departments of health. Local, regional and (bi)national benchmarks, augmented with online dashboard indicator reporting will enable local targeting of quality improvement efforts.
Keywords
Adult; Australia/epidemiology; *Carcinoma, Non-Small-Cell Lung/epidemiology/therapy; Humans; *Lung Neoplasms/epidemiology/therapy; New Zealand/epidemiology; Registries; Preventive medicine; Public health; Quality in health care; RESPIRATORY MEDICINE (see Thoracic Medicine); Respiratory tract tumours
Department(s)
Radiation Oncology; Chief Nursing Officer
PubMed ID
36038161
Open Access at Publisher's Site
https://doi.org/10.1136/bmjopen-2022-060907
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2025-04-04 06:56:54
Last Modified: 2025-04-04 06:57:43

© 2025 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙